The hot list of policies for the new Labour government in the UK, laid out in the King's Speech today, focused mainly on economic growth but included several announcements related to health
Faced with a dramatic rise in sexually transmitted infections, including syphilis, chlamydia, and gonorrhoea in the US, the US government has, for the first time, backed the use of an
The US FDA has approved a human papillomavirus (HPV) self-sampling solution developed by Roche that allows patients to collect a sample themselves in a healthcare setting.
New data suggests that the benefits of Novo Nordisk’s GLP-1 agonist semaglutide in preventing cardiovascular diseases may not simply be a result of weight loss.
A growing number of patients and healthcare providers alike are focussing on preventative health and wellbeing measures, rather than relying on drugs alone as a post-diagnosis cure.
The EMA's human medicines committee has recommended against approval of Eisai and Biogen's Alzheimer's disease therapy Leqembi, after regulators in the US, China and Japan gave a green ligh